Meet Kit Thorpe: CFGI’s Connecticut Practice Leader Who’s Always in Search of a New Challenge

In a career that spans a wide variety of unique professional environments, it seems like Kit Thorpe has seen it all.


A Guide to Accounting for an Efficient Life Sciences IPO: Streamlining Finance Processes When Going Public

Going public is a momentous occasion for any life sciences or biotechnology company, but the road to an IPO is littered with obstacles.


A Guide to Bringing a UK Biotech Company to US Public Markets

With the United States’ thriving IPO market, low volatility and large pool of investors, many U.


The Ultimate Guide to a Life Sciences IPO

The life sciences industry is in the middle of an IPO boom, with the 10 highest-valued biotech IPOs raising $3.


The Future Is Already Here, and CFOs Need to Transform Finance to Survive

Download the Whitepaper

Meet Kelly Provost: A Leader in CFGI’s Life Sciences Capital Markets

Kelly Provost is a leader in CFGI’s Life Sciences Capital Markets practice and has dedicated her career to supporting companies that are trying to cure diseases and save lives, making a difference in the lives of people across the world.


Meet Melanie Kavanagh: A Committed Accounting and Finance Leader at CFGI’s SF Office

Melanie Kavanagh’s promotion to Partner has been an achievement in the making since the day she walked in the doors at CFGI in 2012.


Clene Nanomedicine Inc. Closes Business Combination with SPAC Tottenham Acquisition I Limited

CFGI’s Capital Markets team assisted Clene Nanomedicine (“Clene”) (NYSE: CLNN) with its SPAC merger with Tottenham Acquisition I Limited (“Tottenham”).


Case Study: Reverse Acquisition between Private Operating Company and Public Registrant